Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02717832 · ClinicalTrials.gov registry record · NA
Protection Against Insulin Resistance in Obesity
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02717832 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 26 participants.
The verdict
NCT02717832, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The overall goal of this project is to identify factors that "protect" some obese adults from becoming insulin resistant. Identifying mechanisms that help protect some obese adults from developing insulin resistance could lead to novel, targeted therapeutic and/or preventative strategies for obese adults who are insulin resistant.
Interventions
- DRUG hyperinsulinemic-euglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02717832
The ClinicalTrials.gov registry entry for NCT02717832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hyperinsulinemic-euglycemic clamp is the first listed.
NCT02717832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02717832 about?
NCT02717832 is a clinical study titled "Protection Against Insulin Resistance in Obesity". The overall goal of this project is to identify factors that "protect" some obese adults from becoming insulin resistant. Identifying mechanisms that help protect some obese adults from developing insulin resistance could lead to novel, targeted therapeutic and/or preventative strategies for obese a...
What is the current status of trial NCT02717832?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-03. Estimated completion is 2019-08-09.
What interventions are being tested in trial NCT02717832?
The interventions under investigation include: hyperinsulinemic-euglycemic clamp (DRUG).
Who is sponsoring clinical trial NCT02717832?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.